Trends in incidence, treatment, and relative survival of colorectal cancer in the Netherlands between 2000 and 2021

The epidemiology of colorectal cancer (CRC) has changed rapidly over the years. The aim of this study was to assess the trends in incidence, treatment, and relative survival (RS) of patients diagnosed with CRC in the Netherlands between 2000 and 2021. 2 75667 patients diagnosed with CRC between 2000...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2024-07, Vol.205, p.114104, Article 114104
Main Authors: Swartjes, Hidde, Sijtsma, Femke P.C., Elferink, Marloes A.G., van Erning, Felice N., Moons, Leon M.G., Verheul, Henk M.W., Berbée, Maaike, Vissers, Pauline A.J., de Wilt, Johannes H.W.
Format: Article
Language:English
Subjects:
Colorectal neoplasms
Epidemiology
Incidence
Survival analysis
Therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The epidemiology of colorectal cancer (CRC) has changed rapidly over the years. The aim of this study was to assess the trends in incidence, treatment, and relative survival (RS) of patients diagnosed with CRC in the Netherlands between 2000 and 2021. 2 75667 patients diagnosed with CRC between 2000 and 2021 were included from the Netherlands Cancer Registry. Analyses were stratified for disease extent (localised: T1-3N0M0; regional: T4N0M0/T1-4N1-2M0; distant: T1-4N0-2M1) and localisation (colon; rectum). Trends were assessed with joinpoint regression. CRC incidence increased until the mid-2010s but decreased strongly thereafter to rates comparable with the early 2000s. Amongst other trend changes, local excision rates increased for patients with localised colon (2021: 13.6 %) and rectal cancer (2021: 34.9 %). Moreover, primary tumour resection became less common in patients with distant colon (2000–2021: 60.9–12.5 %) or rectal cancer (2000–2021: 47.8–6.9 %), while local treatment of metastases rates increased. Five-year RS improved continuously for localised and regional colon (97.7 % and 72.0 % in 2017, respectively) and rectal cancer (95.2 % and 76.3 % in 2017, respectively). The rate of anti-cancer treatments decreased in distant colon (2010–2021: 80.3 % to 67.2 %; p 
ISSN:0959-8049
1879-0852
1879-0852
DOI:10.1016/j.ejca.2024.114104